Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Renal Disease Market

Veterinary Renal Disease Market - By Type (Treatment, Diagnosis), Animal (Bovine, Canine, Feline, Equine), Indication (Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis), Global Forecast (2024 – 2032)

  • Report ID: GMI8426
  • Published Date: Mar 2024
  • Report Format: PDF

Veterinary Renal Disease Market Size

Veterinary Renal Disease Market size was valued at USD 15.9 billion in 2023 and is predicted to reach USD 26.5 billion by 2032, showcasing growth of 5.9% from 2024 to 2032 period. The growth of this market can be attributed to factors such as rise in pet ownership and advances in animal diagnostics.

Veterinary Renal Disease Market

Also, rising prevalence of renal diseases in animals, growing focus on renoprotective diets of animals, and increased awareness among pet owners and veterinarians are expected to fuel the growth market. According to the report published by the International Renal Interest Society in 2023, the prevalence of CKD is estimated to be 0.5-1% in dogs and 1-3% in cats. However, it increases with age, specifically in cats with reported prevalence of 80% in the geriatric cat population. Thus, adoption of renal disease treatment and diagnosis in such population will spur the market progress.

Veterinary renal disease refers to any condition or disease affecting the kidneys of animals, including domestic pets and livestock. These conditions may involve structural abnormalities, functional disturbances, or inflammatory processes within the kidneys, leading to impaired kidney function and potential complications affecting other organ systems.

Veterinary Renal Disease Market Trends

  • Increasing pet ownership trend has led to a greater demand for veterinary services and products aimed at addressing the health needs of pets, including the diagnosis, treatment, and management of renal disease. This trend is expected to continue driving growth in the market.
  • Moreover, pet owners are increasingly willing to invest in diagnostic testing to ensure the early detection and management of health conditions in their pets. This includes routine bloodwork, urinalysis, and imaging studies such as ultrasound, which can aid in the early diagnosis of renal disease among pets. Thus, the growing demand for diagnostic testing fuels the growth of the market.

Veterinary Renal Disease Market Analysis

Veterinary Renal Disease Market, By Type, 2021 – 2032 (USD Billion)

The market based on type is segmented into treatment and diagnosis. The treatment segment accounted for majority of market share of 67.3% in 2023 and is expected to dominate throughout the analysis period.

  • The segmental growth is attributed to the growing prevalence of kidney disorders in animals, that increases the demand for effective treatment options. Also, the necessity measures to manage and alleviate renal conditions in animals is on the rise with an increasing number of animals being diagnosed.
  • Moreover, veterinarians have a wide range of tool to address several stages and kinds of renal complications in animals. Hence, the proactive and preventive healthcare highlights the significance of treatment products, thereby augmenting the segment growth.


Veterinary Renal Disease Market, By Animal Type (2023)

The veterinary renal disease based on animal type is classified into bovine, canine, feline, equine, and other animal types. The feline animal type dominated the market and was valued at USD 6.7 billion in 2023.

Chronic kidney disease is a prevalent condition among aging cats, and its incidence is on the rise. This trend drives the demand for diagnostic tests, treatments, and management strategies specific to feline CKD. These factors collectively contribute to cats having the highest prevalence of veterinary renal illnesses compared to dogs, horses, and cows.

For instance, according to the data published by American Veterinary Medical Association in 2021, chronic kidney disease (CKD) in cats ranged between 2% - 20%. For cats older than 10 - 15 years, this number rise up to 30% - 80%. Thus, growing prevalence of CKD among cats along with increasing emphasis on early diagnosis is projected to accelerate the market growth.

Based on indication, the veterinary renal disease market is divided into renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, and other indications. The renal cystitis segment accounted for significant market position and is predicted to reach USD 7.5 billion by 2032.

  • Renal cystitis is a urinary bladder inflammation which is common and recognizable indication as it occur frequently with or ahead of other renal diseases. Therefore, increasing prevalence of renal cystitis is one the major factor promoting market growth.
  • Moreover, cystitis infection can progress to other kidney-related complications and potentially develop into pyelonephritis. Also, renal cystitis is associated with bacterial infections that ascend from the lower urinary system and impact the kidneys. Hence, the interplay of these factors collectively contributes to the expansion of this segment.


North America Veterinary Renal Disease Market, 2020 – 2032 (USD Billion)

North America veterinary renal disease market accounted for USD 7 billion revenue in 2023 and is anticipated to grow at CAGR of 5.7% between 2024 and 2032 period.

  • An important factor contributing to market expansion is the increasing emphasis on comprehensive animal healthcare throughout the region. As per data from the American Pet Products Association, there were 65.1 million households in the U.S. owning pets during 2023-24. Thus, adoption of pet-owning households underscores the increasing emphasis on holistic animal healthcare, serving as a significant factor propelling the market expansion in the region.
  • Further, presence of key players, increasing R&D activities along with growing awareness pertaining to early diagnosis of renal diseases among animals will supplement the market growth.

Veterinary Renal Disease Market Share

The veterinary renal disease industry is characterized by the presence of several key players offering innovative solutions to healthcare providers. Leading companies in this market include Boehringer Ingelheim International GmbH, Zoetis Inc., and Elanco Animal Health Incorporated, among others. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

Veterinary Renal Disease Market Companies

Prominent players operating in the veterinary renal disease industry include:

  • Boehringer Ingelheim International GmbH
  • Dechra Pharmaceuticals
  • Elanco Animal Health Incorporated
  • General Mills Inc.
  • Hill's Pet Nutrition, Inc.
  • IDEXX Laboratories, Inc.
  • The J.M. Smucker Company
  • Mars Incorporated
  • Merck & Co., Inc.
  • Nestle Purina
  • Phibro Animal Health Corporation
  • Zoetis Inc.

Veterinary Renal Disease Industry News

  • In January 2024, Zoetis Inc. expanded its Vetscan Imagyst multi-application diagnostics platform by introducing AI Urine Sediment analysis. This new application utilizes deep learning artificial intelligence to provide accurate in-clinic sediment analysis of fresh urine for quick treatment decisions by veterinarians. The AI technology ensures consistent and precise results within minutes, enhancing the efficiency of individualized treatment plans for pets and pet owners, thereby strengthening its business segment.
  • In June 2023, IDEXX Laboratories, Inc. introduced the IDEXX Cystatin B Test, the first veterinary diagnostic test designed to detect kidney injury in dogs and cats. This innovative test is included in panels assessing renal health. IDEXX plans to expand the test to Europe by 2024. This new addition to IDEXX's renal testing portfolio helps company to enhance their product offerings.

The veterinary renal disease market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

  • Treatment
    • Drugs
      • By drug type
        • NSAIDs
        • Antibiotics
        • Cystine-binding agents
        • Diuretics
        • Other drugs
      • By route of administration
        • Oral
        • Injectable
      • By distribution channel
        • Pharmacies
        • Pet specialty stores
        • E-commerce
        • Other distribution channels
    • Food supplements
  • Diagnosis
    • Test kits & consumables
    • Instruments

Market, By Animal Type

  • Bovine
  • Canine
  • Feline
  • Equine
  • Other animal types

Market, By Indications

  • Renal failure
  • Chronic kidney disease (CKD)
  • Renal cystitis
  • Kidney stones
  • Nephritis
  • Other indications

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East and Africa


Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Veterinary renal disease market size was USD 15.9 billion in 2023 and is expected to register 5.9% CAGR from 2024-2032 owing to the rise in pet ownership and advances in animal diagnostics worldwide.

The treatment segment held 67.3% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to the growing prevalence of kidney disorders in animals, that increases the demand for effective treatment options.

North America veterinary renal disease industry reached USD 7 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the increasing emphasis on comprehensive animal healthcare in the region.

Dechra Pharmaceuticals, Elanco Animal Health Incorporated, General Mills Inc., Hill's Pet Nutrition, Inc., IDEXX Laboratories, Inc., The J.M. Smucker Company, Mars Incorporated, Merck & Co., Inc., and Nestle Purina, are some of the major veterinary renal disease companies worldwide.

Veterinary Renal Disease Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 368
  • Countries covered: 19
  • Pages: 210
 Download Free Sample